TGFB1 and cancer: Prolonged TGF-β exposure has been linked to resistance to anti-cancer drugs such as doxorubicin (DOX), cisplatin, or cyclophosphamide in human mammary epithelial cells (HMLER cell line modified to exhibit EMT features) [163].